Literature DB >> 33409400

Pancreatic cancer and immune checkpoint inhibitors-still a long way to go.

Jessica Bian1, Khaldoun Almhanna2.   

Abstract

Entities:  

Year:  2021        PMID： 33409400      PMCID： PMC7724172          DOI： 10.21037/tgh.2020.04.03

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  8 in total

Review 1.  The interactive role of inflammatory mediators and metabolic reprogramming in pancreatic cancer.

Authors:  Yuuki Ohara; Paloma Valenzuela; S Perwez Hussain
Journal:  Trends Cancer       Date:  2022-05-05

2.  Attenuated Toxoplasma gondii enhances the antitumor efficacy of anti-PD1 antibody by altering the tumor microenvironment in a pancreatic cancer mouse model.

Authors:  Said Ahmed Bahwal; Jane J Chen; Lilin E; Taofang Hao; Jiancong Chen; Vern B Carruthers; Jiaming Lai; Xingwang Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2022-05-12       Impact factor: 4.322

3.  Survival Benefit of Pembrolizumab for Patients With Pancreatic Adenocarcinoma: A Case Series.

Authors:  Li Zhao; Vinit Singh; Anthony Ricca; Patrick Lee
Journal:  J Med Cases       Date:  2022-05-07

Review 4.  Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies.

Authors:  Luman Liu; Prakash G Kshirsagar; Shailendra K Gautam; Mansi Gulati; Emad I Wafa; John C Christiansen; Brianna M White; Surya K Mallapragada; Michael J Wannemuehler; Sushil Kumar; Joyce C Solheim; Surinder K Batra; Aliasger K Salem; Balaji Narasimhan; Maneesh Jain
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

Review 5.  Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma.

Authors:  Alexander G Raufi; Nicholas R Liguori; Lindsey Carlsen; Cassandra Parker; Liz Hernandez Borrero; Shengliang Zhang; Xiaobing Tian; Anna Louie; Lanlan Zhou; Attila A Seyhan; Wafik S El-Deiry
Journal:  Front Pharmacol       Date:  2021-11-30       Impact factor: 5.810

6.  Distinct myeloid antigen-presenting cells dictate differential fates of tumor-specific CD8+ T cells in pancreatic cancer.

Authors:  Adam L Burrack; Zoe C Schmiechen; Michael T Patterson; Ebony A Miller; Ellen J Spartz; Meagan R Rollins; Jackson F Raynor; Jason S Mitchell; Tsuneyasu Kaisho; Brian T Fife; Ingunn M Stromnes
Journal:  JCI Insight       Date:  2022-04-08

Review 7.  Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma.

Authors:  Nebojsa Skorupan; Mayrel Palestino Dominguez; Samuel L Ricci; Christine Alewine
Journal:  Cancers (Basel)       Date:  2022-08-30       Impact factor: 6.575

Review 8.  Pancreatic Cancer: Challenges and Opportunities in Locoregional Therapies.

Authors:  Alaa Y Bazeed; Candace M Day; Sanjay Garg
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.